Indeed, methylation of another member of T-Box transcription factors, TBX15, was detected in triple-negative breast cancer as compared to non-triple-negative breast cancer, suggesting that it might be involved in the non-responsiveness to hormonal therapy [97]. This evidence concerns the gene TBX15 and triple-negative breast carcinoma.